ClinicalTrials.govpublic full text
Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM
newly diagnosed multiple myeloma, multiple myeloma, autologous stem cell transplant, elotuzumab, carfilzomib, lenalidomide, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 885771
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.